A 2026 cross-sectional study of 90 dialysis patients found that vitamin D levels were not directly connected to early signs of heart disease, despite vitamin D being linked to calcium and triglyceride levels. According to Gram Research analysis, body weight emerged as a stronger predictor of low vitamin D than artery thickness, suggesting that weight management may be more important than vitamin D alone for heart health in kidney patients on dialysis.
Researchers studied 90 people with severe kidney disease who need dialysis to see if vitamin D levels affect their heart health. They measured vitamin D in the blood and checked for early signs of heart disease using ultrasound. According to Gram Research analysis, while vitamin D was connected to calcium and fat levels in the blood, it wasn’t directly linked to early heart disease markers. The study suggests that body weight may be more important than vitamin D alone in predicting heart disease risk in dialysis patients.
Key Statistics
A 2026 cross-sectional study of 90 hemodialysis patients found no significant correlation between serum vitamin D levels and carotid intima-media thickness, a marker of early heart disease.
In a study of 46 dialysis patients with thickened arteries and 44 with normal arteries, body weight was identified as an independent predictor of low vitamin D levels (p = 0.016), suggesting weight management may be more important than vitamin D supplementation alone.
A 2026 analysis of 90 kidney dialysis patients found positive correlations between vitamin D and calcium (p = 0.010) and triglycerides (p = 0.025), indicating vitamin D’s role in mineral and fat metabolism.
Among 90 hemodialysis patients studied in 2026, serum calcium levels were significantly associated with artery thickness (p = 0.008), suggesting mineral imbalance may be more directly linked to heart disease risk than vitamin D alone.
The Quick Take
- What they studied: Whether people on kidney dialysis with higher vitamin D levels have less early heart disease
- Who participated: 90 adults with end-stage kidney disease receiving regular hemodialysis treatment, split into two groups based on heart artery thickness measurements
- Key finding: Vitamin D levels were not directly connected to early heart disease signs, though body weight appeared to be an important factor in vitamin D levels
- What it means for you: If you’re on dialysis, maintaining a healthy weight may be more important than focusing solely on vitamin D for heart health, though vitamin D remains important for bone health. Talk to your doctor about your individual needs.
The Research Details
This was a cross-sectional study, which means researchers looked at a group of people at one point in time rather than following them over years. The 90 dialysis patients were divided into two groups: 44 with normal artery thickness and 46 with thicker arteries (a sign of early heart disease). Researchers measured vitamin D levels, calcium, fats in the blood, and used ultrasound to measure the thickness of the carotid artery in the neck, which is a standard way to detect early heart disease. They used statistical tests to find connections between vitamin D and other measurements.
Cross-sectional studies are useful for finding patterns and connections between different health measurements in a specific group. This approach helps researchers understand what factors might be related to heart disease in dialysis patients, though it can’t prove that one thing causes another. Understanding these connections helps doctors better care for kidney patients who face higher heart disease risk.
The study included a reasonable number of participants (90 people) and used standard medical measurements like ultrasound and blood tests. However, because it’s cross-sectional, it shows relationships at one moment in time and cannot prove cause-and-effect. The study was registered in a clinical trials database, which increases transparency. The relatively small sample size and single-center design mean results should be confirmed with larger studies before making major treatment changes.
What the Results Show
The main finding was surprising: vitamin D levels were not directly connected to early heart disease markers in dialysis patients. However, vitamin D did show positive relationships with calcium and triglycerides (blood fats), meaning higher vitamin D was associated with higher levels of these substances. Vitamin D showed negative relationships with body weight and alkaline phosphatase (an enzyme in the blood). When researchers looked at the two groups separately, the group with thicker arteries had higher calcium levels, but vitamin D levels were similar between groups. Using advanced statistical analysis, body weight emerged as the strongest independent predictor of low vitamin D levels.
Calcium levels were significantly associated with artery thickness, suggesting calcium may play a role in heart disease development in dialysis patients. The study found no significant differences between groups in age, body mass index, how long patients had been on dialysis, diabetes rates, or vitamin D supplementation use. This suggests that vitamin D supplementation alone may not be the key factor in preventing early heart disease in this population.
Previous research has suggested vitamin D might protect against heart disease in the general population. This study’s finding that vitamin D wasn’t directly linked to early heart disease in dialysis patients suggests that kidney disease may change how vitamin D affects the heart. The connection between calcium and heart disease aligns with other research showing that mineral imbalances are particularly important in kidney patients.
This study has several important limitations. It looked at people at only one point in time, so it cannot show whether vitamin D changes affect heart disease development over time. The study included only 90 people from what appears to be a single location, so results may not apply to all dialysis patients. The researchers measured artery thickness with ultrasound, which is good but not as detailed as other imaging methods. The study cannot prove that vitamin D causes or prevents heart disease—it only shows what was associated together at that moment.
The Bottom Line
Based on this research, dialysis patients should focus on maintaining a healthy weight as a priority for heart health. Vitamin D remains important for bone health in kidney patients, so continue taking supplements if your doctor recommends them, but don’t expect vitamin D alone to prevent early heart disease. Ask your doctor about managing calcium levels, as this appeared more directly connected to artery thickness. This is moderate-confidence evidence that should be discussed with your nephrologist (kidney doctor).
This research is most relevant to people with end-stage kidney disease on hemodialysis. It may also interest their doctors and caregivers. People with early-stage kidney disease or those not on dialysis should not assume these findings apply to them. General population readers should note this is specific to a very ill population and doesn’t change typical vitamin D recommendations.
Heart disease develops over years, so any benefits from weight management or mineral balance would take months to years to show up in artery thickness measurements. Don’t expect immediate changes—focus on consistent healthy habits.
Frequently Asked Questions
Does vitamin D prevent heart disease in people on kidney dialysis?
A 2026 study of 90 dialysis patients found vitamin D was not directly connected to early heart disease markers. While vitamin D remains important for bone health, body weight appeared more important for heart health in this population.
What’s the relationship between vitamin D and calcium in dialysis patients?
Research shows positive correlation between vitamin D and calcium levels (p = 0.010). Higher vitamin D was associated with higher calcium, which is important because calcium levels were significantly linked to artery thickness in dialysis patients.
Should dialysis patients take vitamin D supplements?
Yes, vitamin D remains important for bone health in kidney patients. However, this study suggests vitamin D supplementation alone won’t prevent early heart disease. Work with your nephrologist on a complete mineral management plan including weight management.
What’s more important for heart health in dialysis: vitamin D or weight?
A 2026 study found body weight was an independent predictor of vitamin D levels, suggesting weight management may be more directly important for heart health than vitamin D alone in dialysis patients.
Can ultrasound detect early heart disease in kidney patients?
Yes, measuring carotid artery thickness with ultrasound is a standard way to detect early heart disease signs. This study used this method in 90 dialysis patients and found calcium levels, not vitamin D, were most associated with artery thickness.
Want to Apply This Research?
- Track weekly body weight and note any changes in dialysis-related symptoms. Set a target weight range with your doctor and monitor progress weekly to identify trends.
- Work with your dialysis team to set realistic weight management goals. Use the app to log meals, fluid intake (important for dialysis patients), and weekly weigh-ins. Share trends with your healthcare provider during appointments.
- Monthly review of weight trends and correlation with lab results (calcium, vitamin D, triglycerides). Quarterly check-ins with your nephrologist to adjust diet and supplement plans based on progress and lab values.
This research applies specifically to people with end-stage kidney disease on hemodialysis and should not be applied to the general population or people with other kidney conditions. Vitamin D and mineral management in dialysis patients is complex and highly individual. Do not change your vitamin D supplementation, diet, or dialysis regimen based on this study alone. Always consult with your nephrologist (kidney specialist) before making changes to your treatment plan. This article summarizes research findings and is not medical advice. Individual results vary, and your doctor knows your complete medical history.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.